Dr. Petr F. Hausner is a medical oncologist at the University of Maryland Health and is a member of the Greenebaum Comprehensive Cancer Center’s Mesothelioma and Thoracic Oncology Treatment and Research Center. His clinical specialties are hematology/oncology, thoracic oncology, gastrointestinal oncology, and cutaneous oncology. Working with a multidisciplinary team of surgeons, oncologists, and others, he
Dr. Katherine A. Scilla is a medical oncologist at the University of Maryland Medical Center and part of the Greenebaum Comprehensive Cancer Center’s Mesothelioma and Thoracic Oncology Treatment and Research Center Team. She specializes in treating chest and thoracic cancers, including malignant pleural mesothelioma, lung cancer, and thymic cancers. Dr. Scilla is part of a
Mesothelioma is a particularly challenging form of cancer that has proven extremely resistant to traditional treatment protocols. Most patients are offered multimodality treatments that include chemotherapy, and that regimen can lead to a troubling side effect referred to as ‘chemobrain.’ This week researchers have published a study that suggests that it may be caused by
Dr. Jordan D. Miller is a thoracic surgeon and member of the Lung and Thoracic Cancer Team at the University of Kentucky’s UK Markey Cancer Center. He specializes in treating patients with lung cancer, esophageal cancer, malignant pleural mesothelioma, and other conditions, using a variety of high-level techniques including minimally invasive surgery and video-assisted thoracoscopic
Dr. Chao H. Huang is a specialist in the field of clinical hematology and medical oncology at the Kansas University Medical Center and the University of Kansas Cancer Center. As director of the Lung Cancer Program, he leads a multidisciplinary team of radiation and medical oncologists, pathologists, pulmonary medicine specialists, and thoracic surgeons in diagnosing
Dr. Kalpaj R. Parekh is an experienced and accomplished cardiothoracic surgeon at the University of Iowa Hospitals and Clinics, as well as the Holden Comprehensive Cancer Center. While his primary interest is in lung transplantation, his clinical efforts and expertise include surgical care of lung cancer and esophageal cancer patients. His technical skills include lung transplant,
Dr. Muhammad Furqan is a medical oncologist at the University of Iowa’s Holden Comprehensive Cancer Center. As a specialist in lung cancer treatment and research, he has been named Interim Associate Director of Clinical Research and also serves as a Clinical Associate Professor of Internal Medicine-Hematology, Oncology, and Blood & Marrow Transplantation at the Carver
Dr. Chad E. Denlinger is a thoracic surgeon at Indiana University Health in Indianapolis and a tenured Professor of Surgery at Indiana University School of Medicine. An expert in diseases of the chest, his clinical interests include the treatment of lung cancers and esophageal cancers, advanced lung disease, lung transplant, gastroesophageal reflux disease, cardiothoracic surgery,
Dr. Nasser H. Hanna is a specialist in internal medicine with a focus on thoracic oncology. He is the Associate Division Director of the Department of Oncology, as well as the Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research and a Professor of Medicine in the Division of Hematology/Oncology at the
As a pulmonologist and critical care specialist, Dr. Francis D. Sheski is an invaluable member of Indiana University’s Melvin and Bren Simon Comprehensive Cancer Center and the Indiana University School of Medicine in Indianapolis, Indiana. His clinical interests include interventional pulmonology for lung cancer and pleural diseases, and he specializes in bronchoscopy and thoracoscopy. Dr.